Work

Abstract B002: Innovative targeted therapy for metastatic prostate cancer using non-statin HMGCR inhibitor: insights from patient-derived organoids and clinical data in Hong Kong

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.prostateca26-b002

Authors: Salida Ali, Yao CHI, Rong NA

Institution: University of Hong Kong

Language: English

Topic: Cancer, Lipids, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7124846606

Cites:

Cited by:

Related to: